Personnel Information

写真a

NISHIO Miwako


Job title

Associate Professor

Mail Address

The inquiry by e-mail is 《here》

Field Introduction URL

https://labohematology.jimdo.com/

To the head of this page.▲

Graduating School 【 display / non-display 】

  • Tokyo Medical and Dental University, Faculty of Medicine, 2004.03, Graduated

To the head of this page.▲

Graduate School 【 display / non-display 】

  • Tokyo Medical and Dental University, Master's Course, 2006.03, Completed

  • Tokyo Medical and Dental University, Doctor's Course, 2010.03, Completed

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2016.05
    -
    2019.04
    Tokyo Medical and Dental University， Graduate School of Health Care Sciences， Biomedical Laboratory Sciences， Moleculo-genetic Sciences， Laboratory Molecular Genetics of Hematology， Visiting Lecturer
  • 2019.05
    -
    2023.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Biomedical Sciences and Engineering， Division of Biomedical Laboratory Sciences， Department of Laboratory Molecular Genetics of Hematology， Associate Professor
  • 2023.04
    -
    2024.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Biomedical Sciences and Engineering， Division of Biomedical Laboratory Sciences， Hematology and Biophysical Systems Analysis， Associate Professor
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Biomedical Laboratory Sciences， Department of Hematology and Biophysical Systems Analysis， Associate Professor
To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE

  • JAPAN SOCIETY FOR THE STUDY OF OBESITY

To the head of this page.▲

Research Areas 【 display / non-display 】

  • Metabolism and endocrinology

  • Hematology and medical oncology

To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Medical Technologist

To the head of this page.▲
 

Research Theme 【 display / non-display 】

  • Characterization of a novel BATokine that enhances glucose uptake by skeletal muscle cells, 2021.04 - 2024.03

To the head of this page.▲

Published Papers & Misc 【 display / non-display 】

  1. Mizuno M, Ogata Y, Nishihara Y, Nishio M, Katano H, Sekiya I.. Microbiome-based profiles of airborne bacteria to support microbial risk assessment in cleanroom environments Regenerative Therapy. 2025.11; 30 991-998.

  2. Yoshimori M, Nishio M, Ohashi A, Maekawa Y, Shimomaki R, Kurata M, Yoshioka K, Yokota T, Nabeshima R, Arai A.. Expression profiling of Epstein-Barr virus-derived microRNA in systemic chronic active EBV disease. Int J Hematol. 2025.07; ( DOI )

  3. Ohashi A, Nishio M, Yoshimori M, Koike K, Kurata M, Tamai H, Imadome KI, Arai A.. Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease. Sci Rep. . 2025.05; 27 (15(1)): 18569. ( DOI )

  4. Mizuno Mitsuru, Kimbara Saeri, Ichise Hanae, Ishikawa Natsumi, Nishihara Yuto, Nishio Miwako, Sekiya Ichiro. Cleaning methods for biosafety cabinet to eliminate residual mycoplasmas, viruses, and endotoxins after changeover Regenerative Therapy. 2025.03; 28 73-80. ( ichushi )

  5. Mizuno M, Yori K, Takeuchi T, Yamamoto T, Ishikawa N, Kobayashi M, Nishio M, Sekiya I. Evaluation of cleaning methods for change-over after the processing of cell products to avoid cross-contamination risk. Regenerative therapy. 2024.06; 26 489-495. ( PubMed, DOI )

  6. Miwako Nishio, Minori Saito, Mayumi Yoshimori, Yuki Kumaki, Ayaka Ohashi, Eri Susaki, Ichiro Yonese, Megumi Sawada, Ayako Arai. Clinical significance of anti-Epstein-Barr virus antibodies in systemic chronic active Epstein-Barr virus disease. Front Microbiol. 2024.01; 14 1320292. ( PubMed, DOI )

  7. CAEBVのEBV感染細胞由来細胞外小胞は単球のマクロファージへの分化を誘導しHLHの原因となる 2023.10; 85回 1471. ( ichushi )

  8. Takayuki Inoue, Bin Fu, Miwako Nishio, Miyako Tanaka, Hisashi Kato, Masashi Tanaka, Michiko Itoh, Hajime Yamakage, Kozue Ochi, Ayaka Ito, Yukihiro Shiraki, Satoshi Saito, Masafumi Ihara, Hideo Nishimura, Atsuhiko Kawamoto, Shian Inoue, Kumiko Saeki, Atsushi Enomoto, Takayoshi Suganami, Noriko Satoh-Asahara. Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis. Nutrients. 2023.01; 15 (2): ( PubMed, DOI )

  9. Yu Uemura, Ayaka Ohashi, Mayumi Yoshimori, Miwako Nishio, Tsuneaki Hirakawa, Norio Shimizu, Naomi Wada, Ken-Ichi Imadome, Ayako Arai. Plasma interferon-γ concentration: a potential biomarker of disease activity of systemic chronic active Epstein-Barr virus infection Frontiers in Virology. 2022.09; 2 ( DOI )

  10. Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M, Nakamae H, Matsuoka KI, Ara T, Washio K, Onizuka M, Watanabe K, Takahashi Y, Hirakawa T, Nishio M, Sakashita C, Kobayashi T, Sawada A, Ichinohe T, Fukuda T, Hashii Y, Atsuta Y, Arai A. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. American journal of hematology. 2022.06; 97 (6): 780-790. ( PubMed, DOI )

  11. Ohashi Ayaka, Uemura Yu, Yoshimori Mayumi, Wada Naomi, Imadome Ken-Ichi, Yudo Kazuo, Koyama Takatoshi, Nishio Miwako, Arai Ayako. The Plasma Level of IL-1 beta As a Biomarker of Angiopathy in Systemic Chronic Active EBV Infection Front Microbiol. 2022.04; 13 874998. ( DOI )

  12. Ohashi A, Uemura Y, Yoshimori M, Wada N, Imadome KI, Yudo K, Koyama T, Shimizu N, Nishio M, Arai A. The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein-Barr Virus Infection. Frontiers in microbiology. 2022; 13 874998. ( PubMed, DOI )

  13. Oshima Kumi, Yoshimori Mayumi, Ohashi Ayaka, Nishio Miwako, Shimizu Norio, Arai Ayako. Simvastatin Induces Anti-Tumor Effects on Systemic CAEBV In Vitro and In Vivo Journal of St. Marianna University. 2022; 13 (2): 59-68. ( ichushi )

  14. Mayumi Yoshimori, Miwako Nishio, Ayaka Ohashi, Megumi Tateishi, Ayaka Mimura, Naomi Wada, Minori Saito, Norio Shimizu, Ken-Ichi Imadome, Ayako Arai. Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH. Cancers. 2021.10; 13 (20): 5097. ( PubMed, DOI )

  15. 慢性活動性EBV感染症患者血漿中のIL-1βは血管病変のバイオマーカーとなり得る(Plasma level of IL-1β in chronic active EBV infection can be a biomarker of angiopathy) 2021.09; 83回 OS2-5. ( ichushi )

  16. 健常若年成人におけるEBV感染の実態(The survey on Epstein-Barr virus infection of healthy young adults) 2021.09; 83回 OS3-2. ( ichushi )

  17. Yoshimori M, Shibayama H, Imadome KI, Kawano F, Ohashi A, Nishio M, Shimizu N, Kurata M, Fujiwara S, Arai A. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection. Blood advances. 2021.04; 5 (7): 1805-1815. ( PubMed, DOI )

  18. Miwako Nishio, Kumiko Saeki.. Evolving Concept of Brown Adipose Tissue in Humans Endocrinology and metabolism. 2021.01; 5 (1): 155.

  19. Miwako Nishio, Kumiko Saeki.. The remaining Mysteries about Brown Adipose Tissues. Cells. 2020.11; 9 (11): 2449.

  20. Hashimoto S, Nakajima F, Imanishi T, Kawai Y, Kato K, Kimura T, Miyata S, Takanashi M, Nishio M, Tokunaga K, Satake M. Implications of HLA diversity among regions for bone marrow donor searches in Japan. HLA. 2020.07; 96 (1): 24-42. ( PubMed, DOI )

  21. Oka M, Kobayashi N, Matsumura K, Nishio M, Nakano K, Okamura T, Okochi H, Minamisawa T, Shiba K, Saeki K. New Role for Growth/Differentiation Factor 15 in the Survival of Transplanted Brown Adipose Tissues in Cooperation with Interleukin-6. Cells. 2020.06; 9 (6): ( PubMed, DOI )

  22. Masako Oka, Norihiko Kobayashi, Kazunori Matsumura, Miwako Nishio, Kumiko Saeki. Exogenous Cytokine-Free Differentiation of Human Pluripotent Stem Cells into Classical Brown Adipocytes. Cells. 2019.04; 8 (4): ( PubMed, DOI )

  23. Miwako Nishio, Masako Nakahara, Akira Yuo, Kumiko Saeki,. Production of Brown Adipocytes from Human Pluripotent Stem Cells (hES / iPS Cells), 臨床病理. 2017.10; 65 (10): 1134-1137.

  24. Ayaka Ohashi, Aya Murata, Yuichiro Cho, Shizuko Ichinose, Yuriko Sakamaki, Miwako Nishio, Osamu Hoshi, Silvia Fischer, Klaus T Preissner, Takatoshi Koyama. The expression and localization of RNase and RNase inhibitor in blood cells and vascular endothelial cells in homeostasis of the vascular system. PLoS ONE. 2017.03; 12 (3): e0174237. ( PubMed, DOI )

  25. Kitahara Shuji, Matsui Aya, Yoshii Asuka, Kuwahara Yoshikazu, Nishio Miwako, Saeki Kumiko, Ezaki Taichi. Endothelial cell transplantation in tumors restores normal vasculature, reduces tumor hypoxia, and suppresses tumor outgrowth Journal of Oral Biosciences. 2016.11; 58 (4): 150-157. ( ichushi )

  26. Miwako Nishio, Masako Nakahara, Akira Yuo, Kumiko Saeki. Human pluripotent stem cells: Towards therapeutic development for the treatment of lifestyle diseases. World J Stem Cells. 2016.02; 8 (2): 56-61. ( PubMed, DOI )

  27. Miwako Nishio, Masako Nakahara, Chikako Sato, Koichi Saeki, Hidenori Akutsu, Akihiro Umezawa, Kazuyuki Tobe, Kazuki Yasuda, Akira Yuo, Kumiko Saeki . New categorization of human vascular endothelial cells by pro- vs anti-proliferative phenotypes World J Transl Med.. 2015.12; 4 (3): 88-100. ( DOI )

  28. Masako Nakahara, Miwako Nishio, Koichi Saeki, Akira Yuo, Kumiko Saeki . p38 mitogen-activated protein kinase regulates type-I vs type-II phenotyping of human vascular endothelial cells World J Transl Med.. 2015.12; 4 (3): 101-112. ( DOI )

  29. Miwako Nishio, Masako Nakahara, Koichi Saeki, Katsuhito Fujiu, Hiroshi Iwata, Ichiro Manabe, Akira Yuo, Kumiko Saeki . Pro- vs anti-stenotic capacities of type-I vs type-II human induced pluripotent-derived endothelial cells World J Transl Med.. 2015.12; 4 (3): 113-122. ( DOI )

  30. Miwako Nishio, Kumiko Saeki. [Production of Functional Classical Brown Adipocytes from Human Pluripotent Stem Cells]. Seikagaku. 2015.08; 87 (4): 445-449. ( PubMed )

  31. Nishio Miwako, Saeki Kumiko. Differentiation of Human Pluripotent Stem Cells into Highly Functional Classical Brown Adipocytes METHODS OF ADIPOSE TISSUE BIOLOGY, PT A. 2014; 537 177-197. ( PubMed, DOI )

  32. Kitahara Shuji, Nishio Miwako, Morikawa Shunichi, Nakada Kazuko, Yoshii Asuka, Saeki Kumiko, Ezaki Taichi. Transplanting normal endothelial cells into tumor mass retards the tumor growth by vascular reconstruction and vascular normalization FASEB JOURNAL. 2013.04; 27

  33. Miwako Nishio, Takeshi Yoneshiro, Masako Nakahara, Shinnosuke Suzuki, Koichi Saeki, Mamoru Hasegawa, Yuko Kawai, Hidenori Akutsu, Akihiro Umezawa, Kazuki Yasuda, Kazuyuki Tobe, Akira Yuo, Kazuo Kubota, Masayuki Saito, Kumiko Saeki. Production of functional classical brown adipocytes from human pluripotent stem cells using specific hemopoietin cocktail without gene transfer. Cell Metab.. 2012.09; 16 (3): 394-406. ( PubMed, DOI )

  34. Naoko Nakamura, Kumiko Saeki, Masami Mitsumoto, Satoko Matsuyama, Miwako Nishio, Koichi Saeki, Mamoru Hasegawa, Yoshiyuki Miyagawa, Hajime Ohkita, Nobutaka Kiyokawa, Masashi Toyoda, Hidenori Akutsu, Akihiro Umezawa, Akira Yuo. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays. Cell Reprogram. 2012.04; 14 (2): 171-185. ( PubMed, DOI )

  35. Maiko Gokoh, Miwako Nishio, Naoko Nakamura, Satoko Matsuyama, Masako Nakahara, Shinnosuke Suzuki, Masami Mitsumoto, Hidenori Akutsu, Akihiro Umezawa, Kazuki Yasuda, Akira Yuo, Kumiko Saeki. Early senescence is not an inevitable fate of human-induced pluripotent stem-derived cells. Cell Reprogram. 2011.08; 13 (4): 361-370. ( PubMed, DOI )

  36. Silvia Fischer, Miwako Nishio, Sara Dadkhahi, Julia Gansler, Mona Saffarzadeh, Aya Shibamiyama, Nicolé Kral, Nelli Baal, Takatoshi Koyama, Elisabeth Deindl, Klaus T Preissner. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb. Haemost.. 2011.02; 105 (2): 345-355. ( PubMed, DOI )

  37. Miwako Nishio, Takatoshi Koyama, Shinsaku Hirosawa. [Proteasome degradation of protein C and plasmin inhibitor mutants: molecular mechanism of congenital protein deficiency]. Rinsho Byori. 2009.08; 57 (8): 737-745. ( PubMed )

  38. Silvia Fischer, Miwako Nishio, Saskia C Peters, Marlene Tschernatsch, Maureen Walberer, Susanne Weidemann, Regina Heidenreich, Pierre O Couraud, Babette B Weksler, Ignacio A Romero, Tibo Gerriets, Klaus T Preissner. Signaling mechanism of extracellular RNA in endothelial cells. FASEB J.. 2009.07; 23 (7): 2100-2109. ( PubMed, DOI )

  39. Miwako Nishio, Takatoshi Koyama, Masako Nakahara, Nagisa Egawa, Shinsaku Hirosawa. Proteasome degradation of protein C and plasmin inhibitor mutants. Thromb. Haemost.. 2008.09; 100 (3): 405-412. ( PubMed )

  40. Masako Nakahara, Takatoshi Koyama, Fumie Nakazawa, Miwako Nishio, Aya Shibamiya, Shinsaku Hirosawa. Gradually glycosylated protein C mutants (Arg178Gln and Cys331Arg) are degraded by proteasome after mannose trimming. Thromb. Haemost.. 2004.12; 92 (6): 1284-1290. ( PubMed, DOI )

▼display all

To the head of this page.▲

Books etc 【 display / non-display 】

  1. Miwako Nishio, Kumiko Saeki. Methods Enzymol. Academic Press， 2014 Differentiation of human pluripotent stem cells into highly functional classical brown adipocytes

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Miwako Nishio, Ayaka Ohashi, Mayumi Yoshimori, Kaoru Koike, Morito Kurata, Ayako Arai. Effects of Venetoclax, a BCL2 Inhibitor, in Systemic Chronic Active Epstein-Barr Virus Disease. 日本血液学会 2025.10.12

  2. Miwako Nishio, Mayumi Yoshimori, Saki Mizutani, Yuri Maekawa, Runa Shimomaki, Kanokp Chihara, Ayako Arai. Investigating the Pathogenesis of CAEBV: our approaches today and future. 日本癌学会 international session 2025.09.26 金沢

  3. Miwako Nishio Saki Mizutani, Airi Minamikawa, Mayumi Yoshimori, Ayako Arai. Investigating the Pathogenic Mechanisms of Angiopathy in Systemic Chronic Active Epstein-Barr Virus Disease Using Endothelial Cells Derived from Induced Pluripotent Stem Cells. 欧州血液学会 2025.06.13

  4. Y.MAEKAWA, M.NISHIO, M.YOSHIMORI, K.YOSHIOKA, R.HARA, T.YOKOAA, R.NABESHIMA, A.ARAI. EBV-derived microRNAs regulate proliferation and activation of EBV-infected cells in sCAEBV. 日本血液学会国際シンポジウム 2025.05.17

  5. Hiroshi Yasui, Aika Fuseya, Masahide Yamamoto, Miwako Nishio, Yu Uemura, Keisuke Tanaka, Yoshihiro Umezawa, Kumi Oshima, Fumiaki Sano, Takehiko Mori, Masanao Sasaki, Akihiro Hirakawa, Ryuji Koike, Ken-Ichi Imadome, Shouichi Ohga, Ayako Arai. Clinical Features and Prognostic Factors of Adult Systemic Chronic Active Epstein-Barr Virus Disease: A Retrospective Analysis Using Japanese Registry Data. 韓国血液学会ICKSH 学術集会 2025.03.27

  6. M. NISHIO, M. YOSHIMORI, K. YOSHIOKA, Y. MAEKAWA, R. HARA, T. YOKOTA, R. NABESHIMA, A. ARAI. Functional Analysis of EBV-Derived MicroRNAs in Systemic Chronic Active EBV Disease Using Novel Antisense Oligonucleotides. ASH Annual meeting 2024.12.07

  7. 福田 笑夏, 吉森 真由美, 南川 愛莉, 水谷 咲, 新井 文子, 西尾 美和子. 慢性活動性EBウイルス病患者由来iPS細胞から分化誘導した単球の特性解析. 日本血液学会学術集会 2024.10.12

  8. 吉森 真由美, 西尾 美和子, 吉岡 耕太郎, 前川 友璃, 原 倫太朗, 横田 隆徳, 鍋島 竜介, 新井 文子. EBV由来マイクロRNAを標的とした核酸医薬のEBV関連T/NKリンパ増殖性疾患に対する効果. 日本血液学会学術集会 2024.10.12

  9. 上村 悠, 西尾 美和子, 下牧 瑠那, 吉森 真由美, 大橋 彩香, 伏屋 愛加, 宮部 斉重, 新井 文子. 全身性慢性活動性EBウイルス病の診断と治療効果判定におけるCXCL10の意義. 日本血液学会学術集会 2024.10.12

  10. 西尾 美和子, 緒方 勇亮, 吉森 真由美, 伏屋 愛加, 大橋 彩香, 須田 亙, 新井 文子. 慢性活動性EBウイルス病(sCAEBV)における腸内細菌叢のメタゲノム解析. 日本血液学会学術集会 2024.10.12

  11. Mayumi Yoshimori, Miwako Nishio, Kotaro Yoshioka, Yuri Maekawa, Rintaro Hara, Takanori Yokota, Ryusuke Nabeshima, Ayako Arai. The Efficacy of Oligonucleotide Therapeutics on EBV-positive T- or NK-cell Lymphoproliferative Diseases Targeting EBV derived microRNAs. 日本核酸医薬学会 2024.07.17

  12. Miwako Nishio, Airi Minamikawa, Mayumi Yoshimori, Emika Fukuda, Saki Mizutani, Ayaka Ohashi, Ayako Arai. Elucidating the Pathogenic Mechanisms of Angiopathy in Systemic Chronic Active Epstein-Barr Virus Disease through Induced Pluripotent Stem Cell-Derived Endothelial Cells. The International Symposium on EBV & KSHV 2024.07.01

  13. Hroshi Yasui, Aika Fuseya, Miwako Nishio, Masahide Yamamoto, Yu Uemura, Keisuke Tanaka, Yoshihiro Umezawa, Kumi Oshima, Fumiaki Sano, Takehiko Mori, Masanao Sasaki, Akihiro Hirakawa, Ryuji Koike, Ken-ichi Imadome, Shoichi Ohga, Ayako Arai. Clinical Features and Prognostic Factors of Adult Systemic Chronic Active Epstein-Barr Virus Disease: A Retrospective Analysis using Japanese Registry Data. The International Symposium on EBV & KSHV 2024.07.01

  14. Aika Fuseya, Miwako Nishio, Masahide Yamamoto, Yu Uemura, Keisuke Tanaka, Yoshihiro Umezawa, Kumi Oshima, Fumiaki Sano, Takehiko Mori, Masanao Sasaki, Akihiro Hirakawa, Ryuji Koike, Hiroshi Yasui, Ken-ichi Imadome, Shoichi Ohga, Ayako Arai. Clinical Features and Prognostic Factors of Adult Systemic Chronic Active Epstein-Barr Virus Disease: A Retrospective Analysis Using Japanese Registry Data. The European Hematology Association 2024.06.14

  15. 洲崎 瑛莉, 吉森 真由美, 齊藤 美緑, 福田 笑夏, 大橋 彩香, 西尾 美和子, 新井 文子. CAEBVのEBV感染細胞由来細胞外小胞は単球のマクロファージへの分化を誘導しHLHの原因となる. 日本血液学会学術集会 2023.10.01

  16. Bin Fu, Miyako Tanaka, Kozue Ochi, Emi Saita, Michiko Itoh, Miwako Nishio, Atsushi Enomoto, Takayuki Inoue, Noriko Satoh-Asahara, Takayoshi Suganami. Natural bioactive flavonoid Taxifolin prevents the development of hepatic steatosis, fibrogenesis and tumorigenesis in a mouse model of NASH. 第96回日本内分泌学会学術総会 2023.06.01

  17. 付 彬, 田中 都, 越智 梢, 才田 恵美, 伊藤 美智子, 西尾 美和子, 榎本 篤, 井上 隆之, 浅原 哲子, 菅波 孝祥. 天然の生理活性フラボノイドTaxifolinはNASHモデルマウスにおける脂肪肝、線維化、腫瘍形成を抑制する(Natural bioactive flavonoid Taxifolin prevents the development of hepatic steatosis, fibrogenesis and tumorigenesis in a mouse model of NASH). 日本内分泌学会雑誌 2023.05.01

  18. Ayaka Ohashi, Mayumi Yoshimori, Miwako Nishio, Kaoru Koike, Norio Shimizu, Kazuo Yudo, Morito Kurata, and Ayako Arai. Will BCL2 be a Potent Therapeutic Target for Systemic Chronic Active Epstein-Barr Virus Disease?. 12th AACR-JCA joint conference 2022.12.10

  19. 加藤 久詞, Fu Bin, 田中 都, 西尾 美和子, 菅波 孝祥 , 浅原 哲子. 植物由来フラボノイド・タキシフォリンの 肥満と脂肪肝/NASH/肝癌の進展抑制作用 -褐色脂肪細胞活性化とFGF21の関与. 第96回日本内分泌学会学術総会 2022.06.01

  20. A. Arai, M. Yamamoto, M. Sato, Y. Onishi, Y. Sasahara, H. Sano, M. Masuko, H. Nakamae, K. Matsuoka T. Ara, K. Washio, M. Onizuka, K. Watanabe, T. Hirakawa, M. Nishio, C. Sakashita, T. Kobayashi, A. Sawada, T. Ichinohe, T. Fukuda, Y. Hashii, Y. Atsuta. The outcomes of sCAEBV Treatment by allo-HSCT: An Analysis of Japanese Registry Data. the 63rd ASH Annual Meeting 2021.12.13

  21. 大橋 彩香, 上村 悠, 吉森 真由美, 和田 尚美, 今留 謙一, 遊道 和雄, 西尾 美和子, 新井 文子. 慢性活動性EBV感染症患者血漿中のIL-1βは血管病変のバイオマーカーとなり得る(Plasma level of IL-1β in chronic active EBV infection can be a biomarker of angiopathy). 日本血液学会学術集会 2021.09.01

  22. 熊木 優喜, 吉森 真由美, 齊藤 美緑, 中家 瞳, 澤田 めぐみ, 西尾 美和子, 新井 文子. 健常若年成人におけるEBV感染の実態(The survey on Epstein-Barr virus infection of healthy young adults). 日本血液学会学術集会 2021.09.01

  23. Mayumi Yoshimori, Megumi Tateishi, Ayaka Ohashi, Ayaka Mimura, Ken-Ichi Imadome, Norio Shimizu, Miwako Nishio, Ayako Ara. IFN-r, which is Produced by EBV-Positive Neoplastic NK-Cells Induces Macrophage Differentiation and Upregulates Blood Coagulation of which Both Causing HLH.. 19th International Symposium on EBV and associated diseases 2021.07.29

  24. Ayaka Ohashi, Yu Uemura, Mayumi Yoshimori, Naomi Wada, Ken-Ichi Imadome, Miwako Nishio, and Ayako Arai. Plasma level of IL-1β in Chronic Active EBV Infection can be a biomarker of angiopathy. 19th International Symposium on EBV and associated diseases 2021.07.29

  25. S Hashimoto, F Nakajima, T Imanishi, Y Kawai, K Kato, T Kimura, M Nishio, M Takanashi, S Miyata, K Tokunaga, M Satake. HLA DIVERSITY AMONG REGIONS AND PREFECTURES FOR BONE MARROW DONOR SEARCHES IN JAPAN. ISBT 2020.12.12

  26. Miwako Nishio. Molecular diagnosis of Chronic Active Epstein-Barr Virus (CAEBV). Medlab Asia 2020 2020.10.22

  27. Megumi Tateishi，Mayumi Yoshimori，Ayaka Ohashi，Shixing Wu， Norio Shimizu，Miwako Nishio，Ayako Arai. The cytokines of EBV+neoplastic NK-cells enhance the procoagulant activity of monocytes causing DIC. 日本血液学会 2020.10.10

  28. Shixing Wu，Mayumi Yoshimori，Megumi Tateishi，Ayaka Ohashi， Norio Shimizu，Miwako Nishio，Ayako Ara. The elucidation of targets of EBV-derived micro-RNA in chronic active EBV infection. 日本血液学会 2020.10.10

  29. Mayumi Yoshimori，Megumi Tateishi，Ayaka Ohashi，Shixing Wu， Kenichi Imadome，Norio Shimizu，Miwako Nishio，Ayako Arai. EBV-positive neoplastic NK-cells induce macrophage differentiation from monocytes, leading to HLH. 日本血液学会 2020.10.10

  30. M.Yoshimori, M.Tateishi, A.Ohashi, S.Wu, K.Imadome, N.Shimizu, M.Nishio, A.Arai. Products of EBV-Positive Neoplastic NK-Cells Induce Differentiation into Macrophages and Procoagulant Activity of Monocytes, which Leads to HLH. European Hematology Association (EHA) 2020.06

  31. 新谷 直樹, 原田 結花, 西尾 美和子, 原田 浩徳. 造血器腫瘍におけるRUNX1、MLLキメラ遺伝子発生プロセスの解明. 日本癌学会総会記事 2016.10.01

  32. Miwako Nishio, Masako Nakahara, Akira Yuo, Kumiko Saeki. Roles for vascular endothelial cells in the development of novel therapeutics for Arteriostenosis. The18th International Vascular Biology Meeting 2014.04.14

  33. Miwako Nishio, Masako Nakahara, Koichi Saeki, Mamoru Hasegawa, Akira Yuo, Kumiko Saeki. CLASSICAL BROWN ADIPOCYTES GENERATED FROM HUMAN PLURIPOTENT STEM CELLS: TOWARDS THERAPUETIC DEVELOPMENT FOR THE TREATMENT OF METABOLIC DISORDERS. 11th International Society of Stem Cell Research (ISSCR) 2013.06.12

  34. Miwako Nishio, Masako Nakahara, Koichi Saeki, Mamoru Hasegawa, Akira Yuo, Kumiko Saeki. PRODUCTION OF FUNCTIONAL CLASSICAL BROWN ADIPOCYTE FROM HUMAN PLURIPOTENT STEM CELLS USING A SPECIAL DIFFERENTIATION COCKTAIL WITHOUT GENETIC MANIPULATION. No. 58 Benzon Synposium 2012.08.26

  35. Miwako Nishio, Masako Nakahara, Koichi Saeki, Mamoru Hasegawa, Akira Yuo, Kumiko Saeki. BROWN ADIPOCYTE DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS WITHOUT GENETIC MANIPULATION. 10th International Society of Stem Cell Research (ISSCR) 2012.06.13

  36. Miwako Nishio, Silvia Fischer, Sara Dadkhahi, Takatoshi Koyama, Klaus T. Preissner. RNase activity and expression in the vascular system. XXIInd Congress of the International Society on Thrombosis & Haemostasis 2009.07.11

  37. Miwako Nishio, Asuka Hoshi, Jihwa Chung, Aya Matsumoto, Takatoshi Koyama. Activation of coagulation by antineoplastic drugs for multiple myeloma. XXIInd Congress of the International Society on Thrombosis & Haemostasis 2009.07.11

  38. Miwako Nishio, Takatoshi Koyama, Masako Nakahara, Nagisa Egawa, Shinsaku Hirosawa. Intracellular degradation of naturally occurring protein C (PC) mutants. XXIst Congress of the International Society on Thrombosis and Haemostasis 2007.07.06

  39. Miwako Nishio, Takatoshi Koyama, Masako Nakahara, Shinsaku Hirosawa. Endoplasmic reticulum-associated degradation of naturally occurring protein C and plasmin inhibitor mutants. XXth Congress of the International Society on Thrombosis & Haemostasis 2005.08.06

▼display all

To the head of this page.▲
 

Performance of duties 【 display / non-display 】

  • ，2023 - Now

  • ，2022.04 - Now

To the head of this page.▲